Melqart Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-94,107	Closed	-$5.96M	–	58
2024 Q3	$5.96M	Sell	94,107 -20,840	-18%	-$1.32M	0.54%	38
2024 Q2	$6.09M	Buy	+114,947	New	+$6.09M	0.5%	36